Literature DB >> 2671581

Shiga-like toxin converting phage of enterohemorrhagic Escherichia coli strain 933.

A D O'Brien1, L R Marques, C F Kerry, J W Newland, R K Holmes.   

Abstract

Production of Shiga-like toxin (SLT) by enterohemorrhagic Escherichia coli (EHEC) is controlled by phage conversion, and specific phages carry either the SLT-I or SLT-II operon. EHEC strain 933 produces both SLT-I and SLT-II. Previous studies demonstrated that the vast majority of phages recovered from strain 993 have hexagonal heads with short tails and encode SLT-II. However, conflicting results were obtained concerning the properties of SLT-I converting phages from strain 933. The present study reexamined the recovery of phages from 933 by various methods and characterized the restriction fragments from strain 933 DNA that hybridized with radiolabeled DNA from the SLT-I converting phage 933J, which has an elongated head with a long tail, and the SLT-II converting phage 933W. In the present study, only SLT-II converting phages like 933W were recovered from strain 933. A set of restriction fragments that hybridized with DNA from phage 933J but not 933W was present both in wild type strain 933 and in the variant 933D, which produces only SLT-I and was shown here to be cured of phage 933W. The sizes of the restriction fragments in strain 933 that were homologous with phage 933J differed, however, from those of phage 933J. These data indicate that the phage we isolated and named 933J probably did not originate from strain 933 as we originally reported. The present evidence demonstrates that strain 933 contains both the SLT-II converting phage 933W and other sequences of DNA homologous with phage 933J that probably represent a defective SLT-I converting phage.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2671581     DOI: 10.1016/0882-4010(89)90080-6

Source DB:  PubMed          Journal:  Microb Pathog        ISSN: 0882-4010            Impact factor:   3.738


  33 in total

1.  Sequence of Shiga toxin 2 phage 933W from Escherichia coli O157:H7: Shiga toxin as a phage late-gene product.

Authors:  G Plunkett; D J Rose; T J Durfee; F R Blattner
Journal:  J Bacteriol       Date:  1999-03       Impact factor: 3.490

2.  Ancestral divergence, genome diversification, and phylogeographic variation in subpopulations of sorbitol-negative, beta-glucuronidase-negative enterohemorrhagic Escherichia coli O157.

Authors:  J Kim; J Nietfeldt; J Ju; J Wise; N Fegan; P Desmarchelier; A K Benson
Journal:  J Bacteriol       Date:  2001-12       Impact factor: 3.490

3.  Genetic typing of shiga toxin 2 variants of Escherichia coli by PCR-restriction fragment length polymorphism analysis.

Authors:  Liesbet De Baets; Imme Van der Taelen; Marina De Filette; Denis Piérard; Lesley Allison; Henri De Greve; Jean-Pierre Hernalsteens; Hein Imberechts
Journal:  Appl Environ Microbiol       Date:  2004-10       Impact factor: 4.792

4.  Dam methyltransferase is required for stable lysogeny of the Shiga toxin (Stx2)-encoding bacteriophage 933W of enterohemorrhagic Escherichia coli O157:H7.

Authors:  Kenan C Murphy; Jennifer M Ritchie; Matthew K Waldor; Anders Løbner-Olesen; M G Marinus
Journal:  J Bacteriol       Date:  2007-11-02       Impact factor: 3.490

5.  Identification and characterization of a newly isolated shiga toxin 2-converting phage from shiga toxin-producing Escherichia coli.

Authors:  M Watarai; T Sato; M Kobayashi; T Shimizu; S Yamasaki; T Tobe; C Sasakawa; Y Takeda
Journal:  Infect Immun       Date:  1998-09       Impact factor: 3.441

6.  Comparison of the glycolipid receptor specificities of Shiga-like toxin type II and Shiga-like toxin type II variants.

Authors:  J E Samuel; L P Perera; S Ward; A D O'Brien; V Ginsburg; H C Krivan
Journal:  Infect Immun       Date:  1990-03       Impact factor: 3.441

7.  Regulation of a muralytic enzyme by dynamic membrane topology.

Authors:  Qingan Sun; Gabriel F Kuty; Arulandu Arockiasamy; Min Xu; Ry Young; James C Sacchettini
Journal:  Nat Struct Mol Biol       Date:  2009-11-01       Impact factor: 15.369

8.  Spread of a distinct Stx2-encoding phage prototype among Escherichia coli O104:H4 strains from outbreaks in Germany, Norway, and Georgia.

Authors:  Lothar Beutin; Jens Andre Hammerl; Eckhard Strauch; Jochen Reetz; Ralf Dieckmann; Ylanna Kelner-Burgos; Annett Martin; Angelika Miko; Nancy A Strockbine; Björn Arne Lindstedt; Detlef Horn; Hella Monse; Bruno Huettel; Ines Müller; Kurt Stüber; Richard Reinhardt
Journal:  J Virol       Date:  2012-07-18       Impact factor: 5.103

9.  Therapy of experimental pseudomonas infections with a nonreplicating genetically modified phage.

Authors:  Steven Hagens; André Habel; Uwe von Ahsen; Alexander von Gabain; Udo Bläsi
Journal:  Antimicrob Agents Chemother       Date:  2004-10       Impact factor: 5.191

10.  Shiga toxin-producing Escherichia coli-associated kidney failure in a 40-year-old patient and late diagnosis by novel bacteriologic and toxin detection methods.

Authors:  Louise D Teel; Brett R Steinberg; Naomi E Aronson; Alison D O'Brien
Journal:  J Clin Microbiol       Date:  2003-07       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.